Journal of Leukocyte Biology eBioscience full spectrum cell analysis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Termeer, C.
Right arrow Articles by Simon, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Termeer, C.
Right arrow Articles by Simon, J. C.
(Journal of Leukocyte Biology. 2001;70:715-722.)
© 2001 by Society for Leukocyte Biology

The role of CD44 during CD40 ligand-induced dendritic cell clustering and maturation

Christian Termeer*, Henning Johannsen*, Thorsten Braun*, Andreas Renkl*, Thomas Ahrens{dagger}, Ralph W. Denfeld*, Mike B. Lappin{ddagger}, Johannes M. Weiss* and Jan C. Simon*

* Department of Dermatology, University of Freiburg, Germany;
{dagger} Department of Biophysical Chemistry, Biocenter Basel, Basel, Switzerland; and
{ddagger} Academic Transfusion Medicine Unit, Department of Medicine, University of Glasgow, United Kingdom

Correspondence: C. Termeer, M.D., Department of Dermatology, University of Freiburg, Hauptstr. 7, D- 79104 Freiburg, Germany. E-mail: Termeer{at}haut.ukl.uni-freiburg.de


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The interaction between CD40 on dendritic cells (DC) and its ligand CD154 has been recognized to be an important feature in the maturation of DC. Here, we were interested in the role of CD44 a surface receptor shown to mediate cell-cell adhesion and binding to Hyaluronic acid (HA). Western blot analysis of human DC stimulated for 3–12 h with CD154 revealed the rapid induction of the 85 kDa standard form of CD44 and an increased HA-binding affinity. Time-lapse video-imaging microscopy of human DC co-cultured on CD154-transfected murine fibroblasts showed that the CD44 up-regulation coincided with the rapid induction of homotypic DC clustering, which did not occur on empty vector-transfected fibroblasts. In this system, addition of anti-CD44s mAbs abrogated DC-cluster formation, thereby inhibiting further maturation, as shown by a reduced TNF-{alpha} production and inhibition of CD154-induced MHC class II up-regulation. However, co-incubation with HA-degrading enzymes induced no changes in the CD154-mediated DC clustering and maturation.

Key Words: hyaluronic acid • MHC • TNF-{alpha} • IL-1ß • CD154


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Dendritic cells (DC) play a pivotal role in the induction of T-cell-mediated immune responses, but their effectiveness is mainly dependent on the differentiation or maturational stage [1 , 2 ]. This process includes distinct phenotypical and functional changes on DC, such as the up-regulation of the costimulatory molecules B7-1 and B7-2, major histocompatibility complex (MHC) class II, and the production of the proinflammatory cytokines tumor necrosis factor {alpha} (TNF-{alpha}) and interleukin (IL)-1ß [2 , 3 ]. A potent, maturational signal is delivered by the ligation of the surface receptor CD40 by its counterreceptor CD154, expressed on activated platelets, basophils, and T-memory cells [1 , 4 , 5 ]. CD40 belongs to the TNF receptor family [6 ], and CD40-mediated signals are especially important for the priming of CD8-mediated immune responses against viral or tumor antigens [2 , 4 , 6 , 7 ]. CD40-mediated maturation, in contrast to stimulation by lipopolysaccharide (LPS) or TNF-{alpha}, induces prolonged DC survival and resistance to the induction of apoptotic cell death by FAS-L (CD95) and MHC class II [8 ]. Furthermore, DC maturation by CD40 ligation results in the production of high levels of IL-12 and polarizes CD4 T-cell responses preferentially to the activation of interferon-{gamma} (IFN-{gamma}) and IL-2 producing TH1 versus TH2 cells [3 , 9 ]. In vivo studies have underlined the potential relevance of CD40-CD154 interaction for the treatment of T-cell-mediated diseases, because a blockade of CD40 dramatically prolonged skin and cardiac allograft survival in mice [10 ].

The first critical step for the direction of the immune response is the DC activation at the site of inflammation, followed by their migration through the lymphatic vessels to the regional lymph nodes [11 ]. During this process, DC will come into close contact with components of the cell extracellular matrix (ECM) and will form clusters within the lymphatic vessels. During DC maturation, all of these functions are mediated by adhesion molecules, with many of them highly expressed on DC, such as intercellular adhesion molecule-1 (ICAM-1), CD11b, CD18, and CD44 [11 ]. We were especially interested in CD44, because it has been proposed to modulate the immune function of DC [12 , 13 ]. CD44 is a polymorphic surface glycoprotein, which can be modified by N- and O-linked glycosylation and alternative RNA splicing [12 , 14 , 15 ]. The major ligand for CD44 is hyaluronan (HA), a macromolecular polysaccharide of a molecular weight up to 1 Mda, which forms widespread networks in the ECM, thus providing a supporting structure for the migration of DC [16 ]. In previous work, we could demonstrate that CD44 is up-regulated on activated human monocytes and mediates an increased hyaluronate-binding capacity [17 , 18 ]. In addition, an activation-dependent induction of CD44-mediated HA binding was found on CD34+ human hematopoetic progenitor cells and T lymphocytes. Up-regulated CD44 expression was accomplished not only with HA binding but also with migratory processes and cell-cell interaction of stromal cells [19 , 20 ]. Indeed, on activated Langerhans cells, which are the DC of the epidermis, we found strong up-regulation of CD44. Blocking CD44 on these cells inhibited the emigration from the epidermis into the lymphatic vessels and could also block a contact hypersensitivity response in vivo [21 ].

Besides its function as an adhesion molecule for cell-cell and cell-ECM interactions, CD44 has been described as a costimulatory factor delivering signals independent of CD28 in CD40-activated B cells to T cells [22 ]. In addition, CD44 was shown to transduce a HA-dependent costimulatory signal to activated human peripheral blood T cells and B cells [23 , 24 ]. Moreover, the interaction of CD44 and HA was shown to induce mitogen-activated protein (MAP) kinase-dependent back-signaling in bone marrow-derived macrophage-like cells, leading to secretion of IL-11ß [25 ].

Therefore, we wished to get further insight into the processes leading to DC maturation using a model of CD154-expressing murine fibroblasts and human monocyte-derived DC [1 ]. Time-lapse video microscopy was applied to investigate the impact of CD44 and its ligand HA on the clustering and maturation of DC. We found that the standard form of CD44 (CD44s) is strongly up-regulated 3–8 h after CD40 ligation. Preincubation of DCs with anti-CD44s mAbs inhibited further maturation, revealing a function for CD44s during the homotypic cell aggregation occurring at the early steps of DC maturation.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Media and reagents
Iscoves-modified (IM) Dulbecco’s modified Eagle’s medium (DMEM, Gibco, Eggenstein, Germany) was supplemented with 10% heat-inactivated fetal calf serum (FCS; PAA, Coelbe, Germany), 1 mM nonessential amino acids, 50 µg/ml penicillin-streptomycin, and 2 mM L-glutamine (all from Gibco). Monoclonal antibodies (mAbs) with specificity for the following human antigens were used: CD40 [early antigen (EA)-5; Calbiochem, Bad Soden, Germany], CD154 (PharMingen, Hamburg, Germany), CD44s (MEM-85; Monosan, Uden, The Netherlands), CD44s (BU 75, BU 52; The Binding Site, Birmingham, UK), CD44s [IM-7; American Type Culture Collection (ATCC), Manassas, VA], anti-HLA-DR (Tu36), B7.1 (BB1), B7.2 (IT2.2), and the anti-mouse CD44s KM201 mAb (ATCC). A CD154 fusion protein was kindly provided by A. Aruffo (Bristol-Myers-Squibb Pharmaceutical Research Institute, Princeton, NJ).

Cell lines
The murine fibroblast cell lines L-M, from C3H mice, CD154-expressing or mock-transfected control cells, were obtained via ATCC.

Generation of human DC
Monocyte-derived DC were prepared as described previously [26 ]. In brief, CD14+ cells were isolated from human buffy coats by immunomagnetic selection using the MACS® magnetic-sorting system (Milteny, Bergisch-Gladbach, Germany) with a bead-labeled anti-CD14 mAb (Milteny). These cells were cultivated for 4 days in IMDM containing granulocyte-macrophage colony-stimulating factor (GM-CSF) and IL-4 to generate immature DC. For CD154-mediated stimulation, 2 x 106 DC were cultivated on monolayers of CD154-expressing murine fibroblasts in IMDM for the indicated periods at 8% CO2 and 37°C.

Flow cytometry
Cells were stained in phosphate-buffered saline (PBS; Gibco) at 4°C for 30 min with unconjugated primary mAb [antigen-specific or control immunogloblin G (IgG)] followed by fluorescein isothiocyanate (FITC)-labeled (Fab)2 fragments of goat anti-mouse IgG (Dianova, Hamburg, Germany) and analyzed with a FACScan using the CellQuestTM software (Becton Dickinson, Heidelberg, Germany). Propidium iodide (5 µg/ml; Sigma, Deisenhofen, Germany) was added to exclude dead cells by appropriate gating. A total of 104 viable cells per sample were analyzed, and mean fluorescence intensities (MFI) were determined using CellQuest® software (Becton Dickinson). Corrected MFI were calculated according to the following formula: MFI(antigen-specific mAb) - MFI(control mAb) = cMFI(antigen-specific mAb).

Human HAS-2 synthetase reverse transcriptase-polymerase chain reaction (RT-PCR)
mRNA was isolated from human DC, freshly isolated human keratinocytes, or HACAT cells according to standard procedures using a quick-prep RNA isolation kit (Pharmacia, Upsala, Sweden). cDNA synthesis was conducted in a 100 µl reaction mix containing 2 µg total cellular RNA, 0.4 U/µl RNAse inhibitor, 1 mM dNTP, 125 pmol random hexanucleotid primer, and 200 U superscript RT (all Gibco). The cDNA samples (15 µl) were added to a 50µl reaction mix containing 200 nM of each oligonucleotide primer (Genescan Europe, Freiburg, Germany), 200 µM dNTPs (Boehringer Mannheim, Indianapolis, IN), 1.5 mM MgCl2, and 1 µl Taq DNA polymerase (Gibco) in 1x reaction buffer. Amplification was performed in a DNA thermal cycler (Perkin Elmer, Foster City, CA) as follows: 1 min at 95°C, 1 min at 60°C, and 2 min at 72°C for 30 cycles, followed by 10 min at 72°C. PCR products were separated on a 1.5% agarose gel and visualized with ethidium bromide using an imaging system (Herolab, Wiesloch, Germany). HAS-2 primer was designed according to the published sequence as follows [27 ]: Upper: 5'-TGGGGTGGAAAAAGAGAAGTC-3'; Lower: 5'-TGAGAAAGAAAGGAAAGAATC-3'; Human ß-actin: Upper: 5'-ACTCTTCCAGCCTTCCTTCC-3'; Lower: 5'-TGTCACCTTCACCGTTCCAG-3'.

HA-RADIO-IMMUNO ASSAY
Supernatants from DC and fibroblasts were collected at the indicated time-points, and the HA content was determined by addition of I125-labeled HA-binding protein (HABP-I125), according to the manufacturer’s instructions (Pharmacia) and analyzed using a Cobra-2® {gamma}-counter (Canberra Packard, Dreieich, Germany).

Analysis of DC-cluster formation
Time-lapse video microscopy was performed using a T.I.L.L.-Photonics digital video imaging system consisting of a TILL-imago CCD camera, a Polychrome II monochromator (TILL Photonics, Munich, Germany) connected to an IMT-2-inverted microscope (Olympus, Hamburg, Germany). The cells were maintained in a heated (37°C) incubation chamber under sterile conditions in RPMI-1640 medium (PTS GmbH, Freiburg, Germany). DC were prelabeled with the membrane dye PKH-2 (Sigma) according to the manufacturer’s instructions.

Proliferation assay
DC were cultivated for 96 h as described above and were then cultivated on CD154-expressing L cells or mock-transfected control L cells for 48 h. The L cells were removed by immunomagnetic depletion, and purity of DC was determined by fluorescein-activated cell sorter (FACS) analysis. DC (1x106) were cultivated with 1 x 105-purified allogeneic T cells (CD4+/CD8+) for 144 h in U-bottom 96-well plates. Then [3H]-thymidine incorporation was determined for the last 18 h of the experiment. Plates were harvested with a Canberra Packard Filter-MateTM, and incorporation of [3H] thymidine was determined by liquid scintillation spectroscopy using a TopCountTM device (both Canberra Packard).

Western blotting
Day 4 DC were cultivated in complete IMDM on CD154-expressing murine fibroblasts or mock-transfected control cells for the indicated time periods. DC were separated from the fibroblasts by immunomagnetic depletion, and 1 x 106 DCs were lysed for 1 h at 4°C in a buffer containing 1% Triton X-100, 10 mM Tris (pH 7.5), 150 mM NaCl, 3 mM ethylenediaminetetraacetate , 50 mM iodoacetamide, 2 mM phenylmethylsulfonyl fluoride, 1 µg/ml leupeptin, and 20 µg/ml aprotinin. Lysates were centrifuged at 9000 g for 10 min, and the protein concentration of the supernatants was determined by UV-absorption at 280 nm. Each lysate (20 µg) was boiled in nonreducing sodium dodecyl sulfate (SDS) sample buffer and separated on an 8% SDS-polyacrylamide gel electrophoresis (PAGE) gel. Proteins were then transferred onto a nitrocellulose membrane. Unspecific binding was blocked by addition of 5% nonfat dried milk powder in TBST for 2 h at room temperature. The membrane was then incubated for 2 h with 2 µg/ml panCD44 mAb BU 75 (The Binding Site). After several washes with TBS-tween, the membranes were incubated for 1 h with a horseradish peroxidase-conjugated goat anti-mouse mAb (Dako, Carpinteria, CA) in TBST. The protein bands were detected using the enhanced chemiluminescence system (Amersham, Braunschweig, Germany). Prestained molecular weight (MW) markers (BioRad, München, Germany) were used to determine the protein size.

Preparation of HA-FITC and HA-binding assay
High MW HA (Healon®, Pharmacia) was labeled with FITC as described previously [28 ]. In brief, 1 mg HA was incubated with 20 µg dibutyltindilaureate, 20 µg FITC, and sodium hydrogencarbonate (all Aldrich, Steinheim, Germany) at 95°C and pH 8 for 30 min. After cooling, the solution was dialyzed against water in a Spectra-pore® tube with a MW cut-off of 500 until no unbound FITC was detectable. For adhesion experiments, 1 x 106 DC were incubated with FITC-HA or unlabeled HA (200 µg/ml) for 45 min at 4°C in the dark and washed twice with PBS. HA binding was determined by FACS analysis of 1 x 105 cells using a FACScan device with the Cell Quest software (Becton Dickinson).

TNF-{alpha} enzyme-linked immunosorbent assay (ELISA)
Supernatants from DC were collected at the indicated time-points, and the content of TNF-{alpha} was determined according to the manufacturer’s instructions (Becton Dickinson), measured at an extinction of 630 nm in a MR 5000 ELISA reader, and analyzed using the Bio-LinxTM software (both Dynatech, Chantilly, VA).


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
We have shown previously that CD44 is involved in the emigration of Langerhans cells from the skin, and blockade of CD44 inhibited their capacity to induce a delayed-type hypersensitivity reaction to a skin hapten in vivo [21 ]. Furthermore, CD44 was also associated with an enhanced cell-cell adhesion, T-cell costimulatory functions, as well as binding to its major ligand, the extracellular matrix component HA [13 , 15 , 21 ]. Because all of these functions are characteristic features of DC maturation, we wished to determine the role of CD44 in an in vitro system that allowed us to discriminate between these functions of CD44 during DC maturation. To this aim, we used the ligation of CD40 by its counter-receptor CD154, which is a very strong inducer of DC maturation [1 , 3 , 6 ].

Homotypic cell clustering is a very early event occurring during DC maturation in vitro. Time-lapse video microscopy was established to analyze the cluster formation of DC on CD154-transfected or mock-transfected fibroblasts. Only CD154-expressing fibroblasts were able to quickly induce firm DC adhesion after 1–2 h followed by DC-cluster formation after 3–8 h of co-incubation (unpublished results and Fig. 1A ). The size of the DC cluster formed by co-incubation on fibroblasts was quantified after 5 h by counting the 10 largest clusters per microscopic field in a Neubauer chamber. The results confirmed that only CD154-treated DC were able to form clusters of 10 cells or more (Fig. 1B) . Further, after 18–24 h, these clusters dissolved to a single-cell suspension of DC, showing the phenotype of matured DC with high expression of surface receptors like MHC class II and B7-costimulatory molecules. These matured DC showed an enhanced capacity to stimulate naive, resting T cells in a standard mixed leukocyte reaction (MLR; Fig. 2 and [1 ]). Again, these changes are restricted to co-incubation on CD154-transfected fibroblasts (Fig. 2) .



View larger version (76K):
[in this window]
[in a new window]
 
Figure 1. CD154 enhances the migratory capacity and induces clustering of human DC. (A) DC were stained with the membrane dye PKH-2, washed, and co-cultured on CD154-expressing fibroblasts (CD154) or mock-transfected control fibroblasts (Ctrl). Photographs were taken at the indicated time-points. (B) The DC-cluster formation on CD154-expressing fibroblasts (solid line) or mock-transfected control fibroblasts (dotted line) was quantified by counting the 20 largest clusters/randomly selected microscopic fields in a Neubauer chamber. The clusters were then attributed to seven defined groups according to their size. The figure shows the mean values of 10 microscopic fields ± SD of a representative of three independent experiments. The vertical line at 33.8 µm marks the border between single-cell clusters of two to three DC or less on the left and clusters with more than three cells on the right. *,·· Statistically significant versus the Ctrl. at P < 0.05; one-way analysis of variance (ANOVA), Dunnett’s test, SigmaStat (Jandel Scientific Software, Corte Madern, CA).

 


View larger version (32K):
[in this window]
[in a new window]
 
Figure 2. CD154-induced functional and phenotypical DC maturation. (A) Monocyte-derived day 4 DC were cultured for 48 h on CD154-transfected murine fibroblasts (bold line) or mock-transfected control fibroblasts (solid line), or labeled with a matched IgG-isotype control mAb (dotted line) and analyzed by FACS for the indicated surface receptors. (B) DC were incubated for 48 h on CD154-transfected murine fibroblasts (CD154) or mock-transfected control fibroblasts (Ctrl.). The cells were separated, washed, and co-incubated for 4 days with 1 x 105 alloreactive T cells at a DC/TC ratio of 1:20. T-cell proliferation was determined on day 5 by addition of 1 µCi 3[H]thymidine for the final 18 h. Results are shown in counts per minute (CPM) ± SD of triplicate wells. A representative of three independent experiments is shown.

 
To determine the expression of CD44, Western blot analysis was performed on DC cell lysates at time-points ranging from 3–12 h. Using the anti-CD44s mAb BU 75, we found a strong induction of an 85 kDa form of CD44 during the first 12 h of DC maturation (Fig. 3A ). Because no bands were detectable above the 85 kDa band, our data point to a distinct up-regulation of the CD44s, which lacks the expression of isoforms.



View larger version (27K):
[in this window]
[in a new window]
 
Figure 3. Up-regulation of CD44- and HA-binding capacity on human DC after CD154 ligation. (A) CD44 expression on human day 4 DC was assessed by Western blotting using the CD44s-specific mAb BU 75. The cells were stimulated with CD154-expressing fibroblasts for the indicated time-points. (B) DC were co-incubated with CD154-expressing fibroblasts for the indicated time points, and the HA-binding capacity was determined by addition of 10 µg/ml FITC-labeled HA followed by FACS analysis. The data show the percentage increase of the HA-binding capacity based on MFI compared with untreated control DC (from above: 23.71; 36.73; 41.68; 57.35; 18.49). A representative of three independent experiments is shown.

 
Although CD44s epitopes are expressed on a broad range of cells, their up-regulation on activated immune cells, like monocytes or T-cells, lead to an altered HA-binding capacity and have been postulated to be involved in cell movement along HA structures in the dermis and the lymph node [17 , 29 ]. To determine whether the up-regulation of CD44 expression in our case was associated with an increase in HA affinity, CD154-stimulated DC were stained with FITC-labeled HA (Fig. 3B) . FACS analysis clearly demonstrated a significantly enhanced HA-binding capacity of up to 150% for CD154-stimulated DC compared with the unstimulated control after 3–12 h, exactly coinciding with the DC clustering and CD44 up-regulation described previously (Figs. 1 and 3) .

Fibroblasts have been described to produce high amounts of HA [30 ]. We wished to determine the amounts of fibroblast-derived HA in our system to use it for functional studies during the CD154-induced DC maturation. This is of advantage, because it avoids the use of exogenously added, potentially contaminated HA, which is important, because DC are highly susceptible to stimulation with bacterial products, and ng amounts of LPS have been shown to induce DC activation [31 ]. To investigate this, RIA assays of cell-culture supernatants were performed, showing that HA was indeed produced in large quantities up to 150 ng/ml by the murine fibroblasts (Fig. 4A ). Further, the HA production was time-dependent but independent of the CD154 transfection of the fibroblasts (Fig. 4A) . In addition, the HA present in our culture system originates solely from the fibroblasts, because human monocyte-derived DC were unable to produce HA even if stimulated with LPS or CD154 (Fig. 4A) . This was confirmed by RT-PCR experiments on the adult form of human HA synthetases, the HA synthetase-2 (HAS-2) [27 ]. In contrast to freshly isolated human keratinocytes or HACAT cells, which strongly express mRNA of HAS-2, DC do not express mRNA of HAS-2 irrespective of their degree of maturation (Fig. 4B) .



View larger version (45K):
[in this window]
[in a new window]
 
Figure 4. Human DC lack the ability to produce HA. (A) The HA content of cell-free culture supernatants of the indicated cells was determined by RIA after 12 h and 24 h. Results are shown in ng/ml HA. A representative of two independent experiments is shown. (B) mRNA synthesis of human HAS-2 synthetase was assessed by RT-PCR. The upper blot shows the HAS-2-specific signal and the lower blot, the ß-actin control. Lanes: A, freshly isolated monocytes; B, DC on day 4; C, DC on day 6; D, the human keratinocyte cell line HACAT; E, freshly isolated human keratinocytes; F, DC stimulated with functional CD154-fusion protein for 48 h on day 4.

 
We now wanted to examine whether the up-regulation of CD44s epitopes and the increase in HA binding were involved in DC-cluster formation and maturation. Indeed, video microscopy after 5 h of co-incubation of CD154-expressing fibroblasts showed a significantly decreased DC-cluster formation when the cells were pretreated with 10 µg/ml CD44s mAbs BU 75 and MEM-85, whereas an IgG-control (Ctrl.) mAb had no effect (Fig. 5 ). To determine the importance of HA present during the maturational process, DC were co-incubated with 16 U/ml Hyaluronidase or 0.5 U/ml of the control enzyme Heparinase 3. This treatment should have substantial impact on the binding of DC to the fibroblasts if a CD44 HA interaction is involved, because Hyaluronidase cleaves HA to oligosaccharides of four to six disaccharide size (unpublished results). This is important, because low MW HA, smaller than 10 oligosaccharide size, can no longer bind to CD44 [32 ]. It is interesting that both enzymes had no effect on the DC-cluster formation (Fig. 5) . These findings could be confirmed by the quantification of the cluster size after 5 h of co-incubation, where the IgG control and the treatment with Hyaluronidase and Heparinase shows the formation of large cluster as seen in Figure 1 for CD154-stimulated DC. In contrast, the CD44s mAbs BU 75 and MEM-85 completely inhibit the formation of large cluster compared with the pattern found for DC co-incubated on mock-transfected fibroblasts (Figs. 1 and 5B) . To further evaluate the consequence of DC-cluster inhibition by the CD44 mAbs, the supernatants were analyzed for their TNF-{alpha} content 8 h after co-incubation by ELISA as a readout parameter for DC maturation [31 ]. The TNF-{alpha} secretion by CD44 mAb-pretreated DC was substantially lowered compared with the IgG-treated control or the enzyme-treated cells (Fig. 6 ). However, we could exclude a direct effect of the mAb or enzymes on DC, because co-incubation on mock-transfected fibroblasts did not induce any release of TNF-{alpha} (Fig. 6) . To extend these findings to a phenotypical level, we analyzed the MHC class II expression of the mAb- or enzyme-pretreated CD154-matured DC by FACS (Fig. 7 ). In agreement with the previous findings, adding anti-CD44s mAbs inhibited the CD154-induced MHC class II up-regulation on DC, whereas Hyaluronidase or Heparinase had no effect. Taken together, these data exclude the need of HA during the CD154-induced maturation of human DC. We could also exclude that DC clustering was depending on the heterotypic interaction of CD44 molecules expressed on murine fibroblasts and on human DC, because addition of the mouse anti-CD44s mAb KM201 was not effective to inhibit MHC-class II up-regulation (Fig. 7) .



View larger version (70K):
[in this window]
[in a new window]
 
Figure 5. CD154-induced DC clustering is affected by CD44 mAbs. (A) DC were preincubated with 10 µg/ml indicated anti-CD44s mAbs for 30 min or alternatively co-incubated with 16 international units (IU)/ml Hyalurionidase or 0.5 IU/ml control-enzyme Heparinase 3 followed by incubation on CD154-expressing fibroblasts. Pictures were taken after 5 h of co-incubation. (B) The DC-cluster formation on CD154-expressing fibroblasts was quantified by microscopic counting in a Neubauer chamber as described in Figure 1 . DC were pretreated as indicated. Results are shown as mean of 10 microscopic fields ± SD of a representative of three independent experiments. *, Statistically significant versus the CD154-treated IgG Ctrl. at P < 0.05; one-way ANOVA, Dunnett’s test, SigmaStat (Jandel Scientific Software).

 


View larger version (16K):
[in this window]
[in a new window]
 
Figure 6. CD44 mAbs inhibit the CD154-induced TNF-{alpha} production of DC. DC were preincubated with 10 µg/ml indicated mAbs or co-incubated with 16 IU/ml Hyaluronidase or 0.5 IU/ml Heparinase 3 on CD154-expressing fibroblasts or mock-transfected control fibroblasts. After 4 h of co-incubation, the supernatants were collected, and the TNF-{alpha} content was determined by ELISA. The results are shown in ng/ml TNF-{alpha} ± SD. *, Statistically significant versus the CD154-treated IgG Ctrl. at P < 0.05; one-way ANOVA, Dunnett’s test, SigmaStat (Jandel Scientific Software).

 


View larger version (15K):
[in this window]
[in a new window]
 
Figure 7. The CD154-induced MHC class II up-regulation on DC is inhibited by CD44 mAbs. DC were preincubated with 10 µg/ml indicated anti-CD44 mAbs, 16 IU/ml Hyaluronidase, or 0.5 IU/ml Heparinase 3 for 30 min, followed by co-incubation with CD154-expressing fibroblasts for 18 h. The DC were separated from fibroblasts, and the MHC class II expression was assessed by FACS. Results are shown as MFI. A representative of two independent experiments is shown.

 

    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The focus of this paper was to gain insight into the regulation and function of CD44 and its ligand Hyaluronan during the early steps of DC maturation. We have shown previously that Langerhans cells, the DC of the epidermis, up-regulate their CD44 expression after stimulation and that antibodies against CD44 standard epitopes inhibited their emigration from the skin [21 ]. Notably, co-injection of an anti-CD44 standard antibody also severely inhibited a delayed-type hypersensitivity reaction to a skin hapten in vivo [21 ]. Therefore, we wished to further elucidate the processes leading to DC maturation using a model of DC-activating, CD154-transfected fibroblasts. Time-lapse video microscopy was applied to investigate the possible role of CD44 and its ligand HA on the clustering and maturation of DC.

The CD44 expression on human monocyte-derived DC has already been studied by Haegel-Kronenberger et al. [13 ]. After 48 h of DC stimulation by TNF-{alpha}, an enhanced expression of a CD44 isoform containing the CD44 splice variants v3, v6, and v9 was found [13 ]. We could complement these findings by showing a strong up-regulation of the CD44 standard form, but no CD44 isoforms, during the first 12 h of DC maturation. On the basis of these findings, an attractive model points to a two-stepped up-regulation of CD44. First, the early, rapid induction of the 85 kDa CD44 standard form on DC occurs 3–12 h after CD40 ligation. Our observations suggest that this form of CD44 is involved in the close cell aggregation, a crucial step for further DC maturation. Similar observations have been made in human long-term bone marrow cultures, which express high levels of CD44s. In these cultures, an anti-CD44s mAb affected myeloid colony formation and maturation [20 ]. In this regard, CD44 binding could intensify cell-cell interactions, because it is closely linked to the cytoskeleton by the small GTPases, Rho, Rac, and Cdc42 [33 34 35 ]. Recent studies show that CD44-mediated Rho signaling is directly involved in the cytoskeletal rearrangements needed for the generation of dendrites in activated B cells [34 ].

How CD44 confers signals to enhance DC maturation is still unclear. A direct enhancing effect has been described for the anti-CD44s mAb J173 on human DC [13 ]. Nevertheless, it has been suggested that CD44 is unable to deliver activating signals directly to the nucleus but works as a bystander receptor to enhance CD3-driven signals in T cells, for example [36 ]. Besides the possibility that CD44 is directly involved in DC maturation [13 ], the close cell contact may be needed to have effective cytokine concentrations in the surrounding of the cells. Here, TNF-{alpha}, which is produced in high amounts once DC are activated, plays a crucial role, because we have shown that binding of TNF-{alpha} by a soluble TNF receptor abolishes DC maturation [31 ].

Another possibility that was also investigated here is that binding of the major ligand HA is responsible for changes in the structural conformation of CD44 and thereby works as an activating cross-linker. Indeed, we found a strong induction of the HA affinity coinciding with CD44 up-regulation during DC maturation. A comparable regulation of the HA-binding capacity has been demonstrated in a variety of immune cells, for example activated monocytes, T cells, and hematopoietic progenitor cells [17 18 19 , 29 ]. However, some authors describe a direct activating effect of HA on DC and T cells [13 , 23 ]. In previous studies, we showed that only low MW HA fragments of oligosaccharide size were able to activate human DC [31 ]. These HA fragments have also been shown to induce intracellular signaling cascades leading to cell activation in murine macrophages [37 ]. However, whether they exert their effects through binding to CD44 is still controversial [31 , 37 , 38 ]. In contrast, high MW HA, as produced by the murine fibroblasts in our culture model, had no influence on the CD40-induced DC maturation, because enzymatic digestion of HA had an enhancing rather than blocking effect, which can be explained by the production of low MW HA in the culture system. These findings are in line with previous results showing that exogenously added high MW HA failed to induce phenotypical or functional changes in immature human or murine DC [31 ]. Further, complete DC maturation can also be achieved by co-culture with a cross-linking anti-CD40 mAb in the absence of HA ([31 ] and unpublished results). A possible explanation for these findings could be the homotypic interaction of CD44 on DC during the first 12 h of maturation. A CD44-CD44 self-interaction has been proposed for cell-cell adhesion of rat pancreatic carcinoma cells but was restricted to CD44 isoforms containing exons v6 and v7, which we could not detect on human DC during the first 12 h of stimulation [14 ]. Nevertheless, other ligands for CD44, such as the recently characterized LYVE-1, might exist on DC, thereby enhancing homotypic cell interactions [39 ].

At a later stage of maturation after 18–24 h, DC up-regulate a CD44 isoform containing the exons v3,v6, and v9 [13 ]. Again, there are similarities to other immune cells such as primary bone marrow cultures and T cells, which have also been shown to up-regulate CD44 isoforms during activation and differentiation [20 , 29 ]. We have shown that in human Langerhans cells and monocytes, the expression of CD44 isoforms is of importance for T-cell binding in the paracortical areas of the draining lymph node [17 , 21 ]. Here, CD44 isoforms might be not only of importance during the T-cell binding but also be responsible for the proposed co-stimulatory role of CD44 [22 , 23 ]. Recent data suggest that this function of CD44 is conferred by cytoskeletal rearrangements and co-localization of MHC class II complexes on the antigen-presenting cell (APC) as well as CD3 and TCR complexes on the T-cell side [34 , 36 ]. Clearly, CD44 is only one amongst other receptors that mediate the formation of the immunological synapse between the APC and the T cell, and similar observations have been made for other receptors linked to the cytoskeleton by small ezrin radixin moesin proteins such as ICAM-1 [35 , 40 ]. However, because it is very unlikely that homotypic DC clustering occurs inside the lymph node, an in vivo correlation for our findings might be the clustering of T cells around a DC following DC activation by T-memory cells via CD40L.

Another possibility is that close cell-cell contacts after CD40 ligation occur earlier, during emigration of the DC from the site of activation. This hypothesis is further supported by in vivo studies in CD154-deficient mice [41 ]. In these mice, the induction of a contact hypersensitivity response was significantly disturbed as a result of the inhibition of early DC emigration from the skin into the regional lymph node [41 ]. Indeed, similarly to cluster formation that we describe as a crucial factor for DC maturation in vitro, activated Langerhans cells form cords within the lymphatic vessels during their emigration from the skin [21 ].

In conclusion, we have demonstrated that during the CD154-induced activation of human monocyte-derived DC, early clustering events are essential for further maturation. During the first 3–12 h, CD44s is strongly up-regulated on human DC, accompanied by an increased HA-binding capacity. However, binding to HA had no direct effect on DC maturation but might be of relevance for DC migration. In contrast, blocking of CD44 by mAbs reduced the homotypic cell aggregation and thereby inhibited further DC maturation.


    ACKNOWLEDGEMENTS
 
This work has been supported by grants from the Deutsche Forschungs-Gemeinschaft (Si-397-7-1/2) and the Center for Clinical Research I, Freiburg, University Medical Center. We thank U. Voith for expert technical assistance.

Received January 20, 2001; revised July 3, 2001; accepted July 9, 2001.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., Van Kooten, C., Durand, I., Banchereau, J. (1994) Activation of human dendritic cells through CD40 cross-linking J. Exp. Med. 180,1263-1272[Abstract/Free Full Text]
  2. Larsson, M., Messmer, D., Somersan, S., Fonteneau, J. F., Donahoe, S. M., Lee, M., Dunbar, P. R., Cerundolo, V., Julkunen, I., Nixon, D. F., Bhardwaj, N. (2000) Requirement of mature dendritic cells for efficient activation of influenza A-specific memory CD8+ T cells J. Immunol. 165,1182-1190[Abstract/Free Full Text]
  3. Cella, M., Scheidegger, D., Palmer-Lehmann, K., Lane, P., Lanzavecchia, A., Alber, G. (1996) Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation J. Exp. Med. 184,747-752[Abstract/Free Full Text]
  4. Mackey, M. F., Gunn, J. R., Maliszewsky, C., Kikutani, H., Noelle, R. J., Barth, R. J. J. (1998) Dendritic cells require maturation via CD40 to generate protective antitumor immunity J. Immunol. 161,2094-2098[Abstract/Free Full Text]
  5. Morse, M. A., Lyerly, H. K., Gilboa, E., Thomas, E., Nair, S. K. (1998) Optimization of the sequence of antigen loading and CD40-ligand-induced maturation of dendritic cells Cancer Res 58,2965-2968[Abstract/Free Full Text]
  6. Van Kooten, C., Banchereau, J. (2000) CD40-CD40 ligand J. Leukoc.Biol. 67,2-17
  7. Terheyden, P., Straten, P., Brocker, E. B., Kampgen, E., Becker, J. C. (2000) CD40-ligated dendritic cells effectively expand melanoma-specific CD8+ CTLs and CD4+ IFN-gamma-producing T cells from tumor-infiltrating lymphocytes J. Immunol. 164,6633-6639[Abstract/Free Full Text]
  8. McLellan, A., Heldmann, M., Terbeck, G., Weih, F., Linden, C., Brocker, E. B., Leverkus, M., Kampgen, E. (2000) MHC class II and CD40 play opposing roles in dendritic cell survival Eur. J. Immunol. 30,2612-2619[Medline]
  9. Koch, F., Stanzl, U., Jennewein, P., Janke, K., Heufler, C., Kampgen, E., Romani, N., Schuler, G. (1996) High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10 J. Exp. Med. 184,741-746[Abstract/Free Full Text]
  10. Larsen, C. P., Elwood, E. T., Alexander, D. Z., Ritchie, S. C., Hendrix, R., Tucker-Burden, C., Cho, H. R., Aruffo, A., Hollenbaugh, D., Linsley, P. S., Winn, K. J., Pearson, T. C. (1996) Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways Nature 381,434-438[Medline]
  11. Kushnir, N., Liu, L., MacPherson, G. G. (1998) Dendritic cells and resting B cells form clusters in vitro and in vivo: T cell independence, partial LFA-1 dependence, and regulation by cross-linking surface molecules J. Immunol. 160,1774-1781[Abstract/Free Full Text]
  12. Katoh, S., Miyagi, T., Taniguchi, H., Matsubara, Y., Kadota, J., Tominaga, A., Kincade, P. W., Matsukura, S., Kohno, S. (1999) Cutting edge: an inducible sialidase regulates the hyaluronic acid binding ability of CD44-bearing human monocytes J. Immunol. 162,5058-5061[Abstract/Free Full Text]
  13. Haegel-Kronenberger, H., de la Salle, H., Bohbot, A., Oberling, F., Cazenave, J. P., Hanau, D. (1998) Adhesive and/or signaling functions of CD44 isoforms in human dendritic cells J. Immunol. 161,3902-3911[Abstract/Free Full Text]
  14. Sleeman, J., Rudy, W., Hofmann, M., Moll, J., Herrlich, P., Ponta, H. (1996) Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity J. Cell Biol. 135,1139-1150[Abstract/Free Full Text]
  15. Lesley, J., English, N., Charles, C., Hyman, R. (2000) The role of the CD44 cytoplasmic and transmembrane domains in constitutive and inducible hyaluronan binding Eur. J. Immunol. 30,245-253[Medline]
  16. Aruffo, A., Stamenkovic, I., Melnick, M., Underhill, C. B., Seed, B. (1990) CD44 is the principal cell surface receptor for hyaluronate Cell 61,1303-1313[Medline]
  17. Weiss, J. M., Renkl, A. C., Ahrens, T., Moll, J., Mai, B. H., Denfeld, R. W., Schopf, E., Ponta, H., Herrlich, P., Simon, J. C. (1998) Activation-dependent modulation of hyaluronate-receptor expression and of hyaluronate-avidity by human monocytes J. Investig. Dermatol. 111,227-232[Medline]
  18. Levesque, M. C., Haynes, B. F. (1997) Cytokine induction of the ability of human monocyte CD44 to bind hyaluronan is mediated primarily by TNF-alpha and is inhibited by IL-4 and IL-13 J. Immunol. 159,6184-6194[Abstract]
  19. Legras, S., Levesque, J. P., Charrad, R., Morimoto, K., Le Bousse, C., Clay, D., Jasmin, C., Smadja-Joffe, F. (1997) CD44-mediated adhesiveness of human hematopoietic progenitors to hyaluronan is modulated by cytokines Blood 89,1905-1914[Abstract/Free Full Text]
  20. Moll, J., Khaldoyanidi, S., Sleeman, J. P., Achtnich, M., Preuss, I., Ponta, H., Herrlich, P. (1998) Two different functions for CD44 proteins in human myelopoiesis J. Clin. Investig. 102,1024-1034[Medline]
  21. Weiss, J. M., Sleeman, J., Renkl, A. C., Dittmar, H., Termeer, C. C., Taxis, S., Howells, N., Hofmann, M., Kohler, G., Schopf, E., Ponta, H., Herrlich, P., Simon, J. C. (1997) An essential role for CD44 variant isoforms in epidermal Langerhans cell and blood dendritic cell function J. Cell Biol. 137,1137-1147[Abstract/Free Full Text]
  22. Guo, Y., Wu, Y., Shinde, S., Sy, M. S., Aruffo, A., Liu, Y. (1996) Identification of a costimulatory molecule rapidly induced by CD40L as CD44H J. Exp. Med. 184,955-961[Abstract/Free Full Text]
  23. Galandrini, R., Galluzzo, E., Albi, N., Grossi, C. E., Velardi, A. (1994) Hyaluronate is costimulatory for human T cell effector functions and binds to CD44 on activated T cells J. Immunol. 153,21-31[Abstract]
  24. Rafi, A., Nagarkatti, M., Nagarkatti, P. S. (1997) Hyaluronate-CD44 interactions can induce murine B-cell activation Blood 89,2901-2908[Abstract/Free Full Text]
  25. Khaldoyanidi, S., Moll, J., Karakhanova, S., Herrlich, P., Ponta, H. (1999) Hyaluronate-enhanced hematopoiesis: two different receptors trigger the release of interleukin-1beta and interleukin-6 from bone marrow macrophages Blood 94,940-949[Abstract/Free Full Text]
  26. Sallusto, F., Lanzavecchia, A. (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha J. Exp. Med. 179,1109-1118[Abstract/Free Full Text]
  27. Watanabe, K., Yamaguchi, Y. (1996) Molecular identification of a putative human hyaluronan synthase J. Biol. Chem. 271,22945-22948[Abstract/Free Full Text]
  28. de Belder, A. N., Wik, K. O. (1975) Preparation and properties of fluorescein-labelled hyaluronate Carbohydr. Res. 44,251-257[Medline]
  29. Lesley, J., Howes, N., Perschl, A., Hyman, R. (1994) Hyaluronan binding function of CD44 is transiently activated on T cells during an in vivo immune response J. Exp. Med. 180,383-387[Abstract/Free Full Text]
  30. Luke, H. J., Prehm, P. (1999) Synthesis and shedding of hyaluronan from plasma membranes of human fibroblasts and metastatic and non-metastatic melanoma cells Biochem. J. 343(Pt. 1),71-75
  31. Termeer, C. C., Hennies, J., Voith, U., Ahrens, T., Weiss, J. M., Prehm, P., Simon, J. C. (2000) Oligosaccharides of hyaluronan are potent activators of dendritic cells J. Immunol. 165,1863-1870[Abstract/Free Full Text]
  32. Tammi, R., MacCallum, D., Hascall, V. C., Pienimaki, J. P., Hyttinen, M., Tammi, M. (1998) Hyaluronan bound to CD44 on keratinocytes is displaced by hyaluronan decasaccharides and not hexasaccharides J. Biol. Chem. 273,28878-28888[Abstract/Free Full Text]
  33. Tsukita, S., Oishi, K., Sato, N., Sagara, J., Kawai, A. (1994) ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons J. Cell Biol. 126,391-401[Abstract/Free Full Text]
  34. Partida-Sanchez, S., Garibay-Escobar, A., Frixione, E., Parkhouse, R. M., Santos-Argumedo, L. (2000) CD45R, CD44 and MHC class II are signaling molecules for the cytoskeleton-dependent induction of dendrites and motility in activated B cells Eur. J. Immunol. 30,2722-2728[Medline]
  35. del Pozo, M. A., Vicente-Manzanares, M., Tejedor, R., Serrador, J. M., Sanchez-Madrid, F. (1999) Rho GTPases control migration and polarization of adhesion molecules and cytoskeletal ERM components in T lymphocytes Eur. J. Immunol. 29,3609-3620[Medline]
  36. Föger, N., Marhaba, R., Zöller, M. (2000) CD44 supports T cell proliferation and apoptosis by apposition of protein kinases Eur. J. Immunol. 30,2888-2899[Medline]
  37. McKee, C. M., Lowenstein, C. J., Horton, M. R., Wu, J., Bao, C., Chin, B. Y., Choi, A. M., Noble, P. W. (1997) Hyaluronan fragments induce nitric-oxide synthase in murine macrophages through a nuclear factor kappaB-dependent mechanism J. Biol. Chem. 272,8013-8018[Abstract/Free Full Text]
  38. Slevin, M., Krupinski, J., Kumar, S., Gaffney, J. (1998) Angiogenic oligosaccharides of hyaluronan induce protein tyrosine kinase activity in endothelial cells and activate a cytoplasmic signal transduction pathway resulting in proliferation Lab. Investig. 78,987-1003[Medline]
  39. Banerji, S., Ni, J., Wang, S. X., Clasper, S., Su, J., Tammi, R., Jones, M., Jackson, D. G. (1999) LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan J. Cell Biol. 144,789-801[Abstract/Free Full Text]
  40. Shinde, S., Wu, Y., Guo, Y., Niu, Q., Xu, J., Grewal, I. S., Flavell, R., Liu, Y. (1996) CD40L is important for induction of, but not response to, costimulatory activity. ICAM-1 as the second costimulatory molecule rapidly up-regulated by CD40L J. Immunol. 157,2764-2768[Abstract]
  41. Moodycliffe, A. M., Shreedhar, V., Ullrich, S. E., Walterscheid, J., Bucana, C., Kripke, M. L., Flores-Romo, L. (2000) CD40-CD40 ligand interactions in vivo regulate migration of antigen-bearing dendritic cells from the skin to draining lymph nodes J. Exp. Med. 191,2011-2020[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
G. de la Rosa, M. Yanez-Mo, R. Samaneigo, D. Serrano-Gomez, L. Martinez-Munoz, E. Fernandez-Ruiz, N. Longo, F. Sanchez-Madrid, A. L. Corbi, and P. Sanchez-Mateos
Regulated recruitment of DC-SIGN to cell-cell contact regions during zymosan-induced human dendritic cell aggregation
J. Leukoc. Biol., May 1, 2005; 77(5): 699 - 709.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
K. Kawamura, K. Iyonaga, H. Ichiyasu, J. Nagano, M. Suga, and Y. Sasaki
Differentiation, Maturation, and Survival of Dendritic Cells by Osteopontin Regulation
Clin. Vaccine Immunol., January 1, 2005; 12(1): 206 - 212.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Termeer, C.
Right arrow Articles by Simon, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Termeer, C.
Right arrow Articles by Simon, J. C.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS